MedTrace Logo

Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators

NCT05932719 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2023-07-10

No results posted yet for this study

Summary

The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments).

Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.

Conditions

Interventions

OTHER

COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.

The following items will be collected * Diagnostic date * Diagnostic stage * Date of surgery * Date of surgery appointment * First antineoplastic treatment date * Last antineoplastic treatment date * Number of treatment cycles recommanded by MDTM

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2022-12-01
Completion
2024-12-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05932719 on ClinicalTrials.gov